|
NKRF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.80179999493313E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62019999638829E-08 |
| Normal-vs-Stage2 |
1.917830E-01 |
| Normal-vs-Stage3 |
2.057700E-02 |
| Normal-vs-Stage4 |
8.649900E-02 |
| Stage1-vs-Stage2 |
3.761200E-01 |
| Stage1-vs-Stage3 |
1.489180E-01 |
| Stage1-vs-Stage4 |
1.611190E-01 |
| Stage2-vs-Stage3 |
9.054000E-01 |
| Stage2-vs-Stage4 |
8.887600E-01 |
| Stage3-vs-Stage4 |
7.382800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53010000225606E-08 |
| Normal-vs-AfricanAmerican |
4.164100E-03 |
| Normal-vs-Asian |
9.049400E-01 |
| Caucasian-vs-AfricanAmerican |
1.949400E-01 |
| Caucasian-vs-Asian |
6.033800E-02 |
| AfricanAmerican-vs-Asian |
3.664600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.2804994538368E-10 |
| Normal-vs-Female |
1.247840E-01 |
| Male-vs-Female |
2.982300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.82559999999788E-05 |
| Normal-vs-Extreme_Weight |
5.29230004264747E-09 |
| Normal-vs-Obese |
2.601900E-03 |
| Normal-vs-Extreme_Obese |
1.955280E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.209200E-01 |
| Normal_Weight-vs-Obese |
3.498000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.847000E-01 |
| Extreme_Weight-vs-Obese |
7.996100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.621200E-01 |
| Obese-vs-Extreme_Obese |
6.783200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.363600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.70230000000294E-05 |
| Normal-vs-Age(61-80Yrs) |
1.202000055045E-09 |
| Normal-vs-Age(81-100Yrs) |
5.14430000042587E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.594400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.955700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.299700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.744900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.397600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.521800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8985999994392E-08 |
| Normal-VS-Type2 PRCC |
5.39810000033114E-07 |
| Normal-VS-KIRP CIMP |
2.695400E-01 |
| Normal-VS-Unclassified PRCC |
2.517800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.672000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.872300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.630000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.532200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.028200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.030600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.48340000178027E-08 |
| Normal-vs-N1 |
3.068800E-01 |
| Normal-vs-N2 |
5.017600E-02 |
| N0-vs-N1 |
1.099670E-02 |
| N0-vs-N2 |
5.044200E-01 |
| N1-vs-N2 |
4.849400E-01 |
|
|
